Form 8-K - Current report:
SEC Accession No. 0001193125-21-248398
Filing Date
2021-08-17
Accepted
2021-08-17 07:17:06
Documents
14
Period of Report
2021-08-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d209834d8k.htm   iXBRL 8-K 31270
2 EX-99.1 d209834dex991.htm EX-99.1 14454
6 GRAPHIC g209834g0817040625316.jpg GRAPHIC 3020
  Complete submission text file 0001193125-21-248398.txt   184434

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dawn-20210816.xsd EX-101.SCH 2894
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dawn-20210816_lab.xml EX-101.LAB 18887
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dawn-20210816_pre.xml EX-101.PRE 11861
7 EXTRACTED XBRL INSTANCE DOCUMENT d209834d8k_htm.xml XML 3499
Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 211180920
SIC: 2834 Pharmaceutical Preparations